AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.
Scott Whitaker, President and CEO of AdvaMed, The Medtech Association®, sent a letter to CMS Administrator Chiquita Brooks-LaSure outlining industry disappointment in the lack of a finalized rule for Transitional…
By Friday, March 1, the Environmental Protection Agency is expected to finalize its regulation for the ethylene oxide (EtO) sterilization of 20 billion, or half, of all medical devices in…
Today, AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the potential government shutdown and the impact it could have on patients:
Today, AdvaMed, The Medtech Association®, released the newest episode of Medtech POV with Scott Whitaker, featuring a conversation with former Senator Richard Burr of North Carolina.
In testimony today before the U.S. House of Representatives Committee on Small Business, Dr. Lishan Aklog urged Congress and the executive branch to consider the dire consequences for patients and…
AdvaMed, the MedTech Association®, submitted comments to the Federal Trade Commission in response to a request for public comment on rulemaking regarding “right to repair” policies. AdvaMed® and AdvaMed®’s Medical…
Today, AdvaMed, The Medtech Association®, announced Kelvyn Cullimore, President and CEO of BioUtah, will serve as the next chair of the State Medtech Alliance (SMTA). The Alliance is a consortium…
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker upon the passage of a research and development expensing tax provision critical to medtech innovation in the…
Today, AdvaMed® President and CEO Scott Whitaker released the following statement in remembrance of Jack Wareham, former CEO and Chairman of Beckman Coulter and recipient of AdvaMed®’s fifth annual Lifetime…